Regeneron Pharmaceuticals Q4 2025 Earnings Preview

Regeneron Pharmaceuticals (REGN) is scheduled to announce Q4 earnings results on Friday, January 30th, before market open.
The consensus EPS Estimate is $10.64 (-11.8% Y/Y) and the consensus Revenue Estimate is $3.78B (-0.3% Y/Y).
Over the last 2 years, REGN has